BioSpace News Archive

Unqork announced that Founder and CEO Gary Hoberman will be the main presenter of MongoDB’s Investor Day Summit and will deliver a Technical Talk at MongoDB World, MongoDB’s signature user conference, in New York on June 18, 2019.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Amneal Pharmaceuticals, Inc. (NYSE: AMRX).

Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that the independent Data Monitoring Committee (“IDMC”) of the Phase III pivotal study of surufatinib in advanced neuroendocrine tumors – extra-pancreatic (“SANET-ep”) has completed a planned interim analysis.

Faron Pharmaceuticals Oy (AIM: FARN), the clinical stage biopharmaceutical company, today announces results from its pharmacokinetic/dynamic YODA study examining the administration of concomitant steroids and Traumakine in healthy volunteers.

Rho, a full-service contract research organization (CRO), will highlight its clinical trial expertise during the Drug Information Association (DIA) Annual Meeting, being held June 23-27 in San Francisco.

Sandoz, a Novartis division and a global leader in biosimilars, today announced data from the Phase III ADMYRA trial demonstrating that the efficacy and safety of biosimilar Hyrimoz® (adalimumab)* matches that of the reference medicine adalimumab** with no clinically meaningful differences in patients with moderate-to-severe rheumatoid arthritis (RA) with inadequate response to disease modifying antirheumatic drugs (DMARDs), including methotrexate (MTX)1

Transgene (Euronext Paris: TNG) (“Transgene” or the “Company”), a biotech company that designs and develops virus-based immunotherapies for the treatment of solid tumors, announces today the launch and terms of a share capital increase with shareholders’ preferential subscription rights for an amount of up to €50 million (issue premium included) (the “Rights Issue”).

Platelet specialists Dr Natalia Dovlatova, Ann White and Bob Humphries announce the launch of their new company – ‘Platelet Services Limited’, which will be based in BioCity Nottingham, UK.

Research published in the open-source journal F1000Research aimed to uncover which clinical outcomes patients consider most important when it comes to decision-making for heart disease treatment options.

CherryCircle Software, the company providing the QbDVision® platform to accelerate the development of manufacturing processes for the pharmaceutical industry, announced today significant new features, including process capability analytics, expanded support for Contract Development and Manufacturing Organizations (CDMOs and CMOs) and consultants, and data import capabilities for faster project setup and data ingestion.